|
CONTENTS
|
|
Introductory Comment
Guy Furness
|
|
Advanced simplification of nasal delivery technology: anatomy + innovative device = added value opportunity
Troels Keldmann
Direct-Haler |
|
Pharmacokinetic attributes of intranasal delivery: case studies and new opportunities
Henry R Costantino Anthony P Sileno Paul H Johnson
Nastech Pharmaceutical Company
|
|
Controlled Particle Dispersion™: effective nasal delivery from a versatile, flexible technology platform
Marc Giroux
Kurve Technology |
|
Nasal delivery of analgesics
Michael T Sheckler
Fred Mermelstein Douglas A Hamilton
Daniel Carr Javelin Pharmaceuticals |
|
Breath-actuated bi-directional delivery sets the nasal market on a new course
OptiNose
|